Folkert W. Asselbergs, Hans L. Hillege, Wiek H. Van Gilst

Slides:

Advertisements

Similar presentations

Volume 4, Pages (September 2014)

Advertisements

F.H. Bender, J. Bernardini, B. Piraino Kidney International

Volume 66, Issue 1, Pages (July 2004)

Associations Between Low Serum Testosterone and All-Cause Mortality and Infection- Related Hospitalization in Male Hemodialysis Patients: A Prospective.

Anemia management in chronic kidney disease

Volume 80, Issue 10, Pages (November 2011)

Progression of renal failure and hypertensive nephrosclerosis

Peter Rossing, Philip Hougaard, Hans-Henrik Parving

John P. Middleton, Patrick H. Pun Kidney International

Genetic variations associated with diabetic nephropathy and type II diabetes in a Japanese population S. Maeda, N. Osawa, T. Hayashi, S. Tsukada, M.

Francesco Paolo Schena Kidney International

Need for better diabetes treatment for improved renal outcome

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease Johannes F.E. Mann, Qi-Long.

Progression of diabetic nephropathy

Anemia as a risk factor for chronic kidney disease

F.H. Bender, J. Bernardini, B. Piraino Kidney International

Comorbidity and confounding in end-stage renal disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Kamila Czene, Ph.D., Kari Hemminki Kidney International

Renal risk scores: Progress and prospects

The epidemiology of chronic kidney disease

U-shaped effect of eGFR and mortality

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Anemia as a risk factor for cardiovascular disease

Fructose intake as a risk factor for kidney stone disease

Volume 73, Issue 12, Pages (June 2008)

Should kidney donors be genotyped for APOL1 risk alleles?

New insights in uremic toxins

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Proteinuria and hypertensive nephrosclerosis in African Americans

Microbiology and outcomes of peritonitis in North America

Methods for guideline development

Cardiovascular disease in pediatric chronic dialysis patients

Volume 87, Issue 1, Pages (January 2015)

The kidney, a cardiovascular risk marker, and a new target for therapy

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 85, Issue 5, Pages (May 2014)

Homocysteine, renal function, and risk of cardiovascular disease

E.A. Friedman, A.L. Friedman, P. Eggers Kidney International

Volume 67, Pages S55-S62 (January 2005)

Volume 66, Pages S18-S21 (November 2004)

Volume 54, Issue 2, Pages (August 1998)

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Organ transplantation goes to the movies

Volume 70, Pages S84-S90 (November 2006)

Volume 66, Issue 5, Pages (November 2004)

Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant Chirag R. Parikh, Peter Mcsweeney,

Volume 55, Pages S3-S16 (June 1999)

Early detection and prevention of diabetic nephropathy: A challenge calling for mandatory action for Mexico and the developing world Ricardo Correa-Rotter,

Volume 70, Issue 7, Pages (October 2006)

Is it the low-protein diet or simply the salt restriction?

Cardiovascular risk in chronic kidney disease

Charles A. Herzog Kidney International

Volume 62, Issue 5, Pages (November 2002)

Volume 75, Issue 1, Pages (January 2009)

Is complement a target for therapy in renal disease?

Volume 67, Issue 5, Pages (May 2005)

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Volume 70, Issue 5, Pages (September 2006)

Volume 75, Issue 7, Pages (April 2009)

James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon

Hisataka Kobayashi, Peter L. Choyke Kidney International

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger Kidney.

Sugar-sweetened beverages and chronic disease

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Framingham score and microalbuminuria: Combined future targets for primary prevention? Folkert W. Asselbergs, Hans L. Hillege, Wiek H. Van Gilst Kidney International Volume 66, Pages S111-S114 (November 2004) DOI: 10.1111/j.1523-1755.2004.09227.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan-Meier analysis illustrating the prognostic value of Framingham risk score in microalbuminuric subjects. The population is divided in three groups according to 10-year risk on cardiovascular disease. Hazard ratios (95% CIs) are given for the groups with a score between 10% to 20% and >20%. Kidney International 2004 66, S111-S114DOI: (10.1111/j.1523-1755.2004.09227.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 The effects of fosinopril and pravastatin on the calculated Framingham risk score and the observed incidence of cardiovascular events during four years of follow-up. Kidney International 2004 66, S111-S114DOI: (10.1111/j.1523-1755.2004.09227.x) Copyright © 2004 International Society of Nephrology Terms and Conditions